Abbott RealTime IDH2 Amplification Reagent Kit
RealTime - 08N82-090
Device Description
A collection of reagents and other associated materials intended to be used to diagnose, monitor or predict the isocitrate dehydrogenase 2 (IDH2) gene mutation status of a clinical specimen, using a nucleic acid technique (NAT). Mutations of the IDH2 gene are commonly found in cases of glioma and acute myeloid leukaemia (AML).
Environmental Conditions
- -15.00
- -25.00
Device Sizes
No Data Available
Device Sterilization
Device Sterile: False
Sterilization Prior To Use: False
Sterilization Methods: No Data Available
Product Codes
Code: OWD
Device Name: Somatic Gene Mutation Detection System
Device Class: 3
Physical State: Test consists of reagents, instrumentation, software and instructions needed to perform the test method.
Definition: The somatic gene mutation detection system is an in vitro diagnostic nucleic acid amplification and real-time detection system for the identification of genetic mutations in DNA extracted from human tumor tissues.
Submission Type ID: 2
Review Panel: PA
Review Code: N/A
Technical Method: N
Gmp Exempt Flag: In vitro amplification and detection of genomic DNA representing a somatic gene mutation from a cancerous specimen of interest.
Life Sustain Support Flag: N
Unclassified Reason: N/A
Implant Flag: N
Target Area: Human clinical specimens of peripheral blood or bone marrow.
Regulation Number: N/A
Third Party Flag: N
Medical Specialty: N/A
Device IdentifiersDevice Id: 00884999047044
Device Type: Primary
DeviceId Issuing Agency: GS1
Contains DI Number: N/A
Package Quantity: N/A
Package Discontinue Date: N/A
Package Status: N/A
Package Type: N/A
GMDN® is a registered trademark of The GMDN Agency. All rights reserved. The information provided on this site includes data supplied by The GMDN Agency ("GMDN Content"), which is used under licence from The GMDN Agency. Any data/information suppliers who wish to extract GMDN Content from this site in order to use it as a basis for creating and supporting commercial services such as alternative categorisation, alternative GMDN Term assignment, mapping to other categorisations or ontologies, or for AI training purposes, must first obtain an appropriate licence from The GMDN Agency. No such activity is permitted without a licence. For more information on obtaining a licence, please contact The GMDN Agency (https://www.gmdnagency.org/contact-us/). None of the GMDN content constitutes any endorsement, advice, representation or warranty about any specific medical devices that may be described by such content; and no representation or warranty is made in relation to instructions for use, suitability for any application, treatment or condition, regulatory status, or any properties of a particular medical device.
GMDN ®. © GMDN Agency 2005-.